findmyKOL

Dipan Shah, MD

Enriched profile

Chief, Division of Cardiovascular Imaging, Department of Cardiology; Beverly B. and Daniel C. Arnold Distinguished Centennial Chair; Professor of Cardiology, Academic Institute; Program Director, Advanced Cardiac Imaging/Cardiovascular Imaging Fellowship · Houston Methodist

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Houston, TX · South Central · United StatesSpecialtyCardiovascular DiseaseFocusCoronary Artery Disease / ACS+1
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2024–2026

Dipan Shah is Chief, Division of Cardiovascular Imaging, Department of Cardiology; Beverly B. and Daniel C. Arnold Distinguished Centennial Chair; Professor of Cardiology, Academic Institute; Program Director, Advanced Cardiac Imaging/Cardiovascular Imaging Fellowship at Houston Methodist. OpenAlex indexes 457 publications with 12,167 citations (h-index 47); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Dipan Shah, MD, is Chief, Division of Cardiovascular Imaging, Department of Cardiology at Houston Methodist (DeBakey Heart & Vascular Center, Houston Methodist Hospital), Houston, TX. The public record shows 457 publications with 12,167 citations (h-index 47), centered on Coronary Artery Disease / ACS, Heart Failure. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 21 companies, 1 NIH-funded awards (2024–2026).

  • Most recent indexed publication: 2026 · European heart journal. Cardiovascular Imaging
  • Top research focus: Coronary Artery Disease / ACS
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 21 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Coronary Artery Disease / ACS2 trialsCoronary Artery Disease2 trialsMitral Valve Insufficiency1 trialHeart Failure1 trialCardiovascular Diseases1 trialVascular Diseases1 trial

Research focus

OpenAlex concept fingerprint
Coronary Artery Disease / ACSHeart Failure

Drugs & molecules

across trials, industry payments and publications
Arcalystgeneric · RilonaceptClinical trials—Industry payments45Publications—Repathageneric · EvolocumabClinical trials—Industry payments21Publications—Leqviogeneric · InclisiranClinical trials—Industry payments12Publications—PerflutrenClinical trials—Industry payments8Publications—Vyndaqelgeneric · TafamidisClinical trials—Industry payments7Publications—GadopiclenolClinical trials—Industry payments6Publications—Attrubygeneric · AcoramidisClinical trials—Industry payments3Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments3Publications—Multaqgeneric · DronedaroneClinical trials—Industry payments2Publications—Camzyosgeneric · MavacamtenClinical trials—Industry payments1Publications—Eliquisgeneric · ApixabanClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Kiniksa Pharmaceuticals, Ltd.Clinical trials—Industry payments35Siemens Medical Solutions USA, Inc.Clinical trials—Industry payments32Amgen Inc.Clinical trials—Industry payments21Kiniksa Pharmaceuticals International, plcClinical trials—Industry payments18Novartis Pharmaceuticals CorporationClinical trials—Industry payments15Ge HealthcareClinical trials—Industry payments11Lantheus Medical Imaging, Inc.Clinical trials—Industry payments8Pfizer Inc.Clinical trials—Industry payments8Guerbet LLCClinical trials—Industry payments6Tactile Systems Technology IncClinical trials—Industry payments4BridgeBio Pharma, Inc.Clinical trials—Industry payments3Dipan ShahClinical trials3Industry payments—HeartFlow, Inc.Clinical trials—Industry payments3Sanofi-Aventis U.S. LLCClinical trials—Industry payments2Abbott LaboratoriesClinical trials—Industry payments1Baxter HealthcareClinical trials—Industry payments1E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Edwards Lifesciences CorporationClinical trials—Industry payments1Impulse Dynamics (USA) Inc.Clinical trials—Industry payments1Jenavalve Technology, Inc.Clinical trials—Industry payments1The Methodist Hospital Research InstituteClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
457publications

Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.

12,167citations

Total citations across indexed works.

47h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
21companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2024–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

All 4 trial records: search, sort and filter.Explore →

Industry payments

Updated 14 Oct 2026

21 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 38 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    88.4%
    Statin27.5%
    Rosuvastatin Calcium59%Atorvastatin Calcium41%
    Part D≥27 patients
    Beta blocker23.9%
    Carvedilol53%Metoprolol Succinate47%
    Part D≥18 patients

    + 8 more classes in this area

  • Blood & clotting

    9.4%
    Factor Xa inhibitor7.1%
    Eliquis100%
    Part D<11 patients
    P2Y12 inhibitor2.4%
    Clopidogrel100%
    Part D<11 patients

  • Metabolism & gastrointestinal

    2.2%
    SGLT2 inhibitor2.2%
    Farxiga100%
    Part D<11 patients
Where care is delivered (Part B)87.7% facility · 12.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 19 publications: search, sort and filter.Explore →

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/dipan-shah

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Dipan-Shah-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/DipanJShah

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • Doximity

    doximity.com/pub/dipan-shah-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    mdvideos.houstonmethodist.org/participant/dipan-shah-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdvideos.houstonmethodist.org ↗
  • Other

    pmc.ncbi.nlm.nih.gov/articles/PMC3782316

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗
  • Other

    scholars.houstonmethodist.org/en/persons/dipan-j-shah

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
  • Other

    houstonmethodist.org/doctor/dipan-shah

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • X / Twitter

    X (Twitter): @DipanJShah

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Fellow

    American College of Cardiology (FACC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org ↗
  • Program Director

    Advanced Cardiac Imaging/Cardiovascular Imaging Fellowship, Houston Methodist

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
  • Guest Editor

    Methodist DeBakey Cardiovascular Journal (special issue on cardiac MRI)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗
  • Editorial Board Member

    Methodist DeBakey Cardiovascular Journal, Division of Cardiovascular Imaging

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →journal.houstonmethodist.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.